help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2008-1180
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Attar, E.
Right arrow Articles by Bulun, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Attar, E.
Right arrow Articles by Bulun, S. E.
Related Collections
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 94, No. 2 623-631
Copyright © 2009 by The Endocrine Society

Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis

Erkut Attar1, Hideki Tokunaga1, Gonca Imir, M. Bertan Yilmaz, David Redwine, Michael Putman, Bilgin Gurates, Rukset Attar, Nobuo Yaegashi, Dale B. Hales and Serdar E. Bulun

Division of Reproductive Biology Research (E.A., H.T., G.I., M.B.Y., S.E.B.), Department of Obstetrics and Gynecology, Feinberg School of Medicine at Northwestern University, Chicago, Illinois 60611; Department of Obstetrics and Gynecology (E.A.), Istanbul University Capa School of Medicine, Istanbul, Turkey; Department of Obstetrics and Gynecology (H.T., N.Y.), Tohoku University, Sendai, Japan 980-8575; Department of Obstetrics and Gynecology (G.I.), Cumhuriyet University School of Medicine, Sivas, Turkey; Department of Obstetrics and Gynecology (D.R.), St. Charles Medical Center, Bend, Oregon 97701; Department of Obstetrics and Gynecology (M.P.), Baylor University Hospital, Dallas, Texas 75246; Department of Obstetrics and Gynecology (B.G.), Firat University School of Medicine, Elazig, Turkey; Department of Obstetrics and Gynecology (R.A.), Yeditepe University Hospital, Kozyatagi, Istanbul, Turkey; and Department of Molecular Physiology and Biophysics (D.B.H.), University of Illinois at Chicago, Chicago, Illinois 60612

Address all correspondence and requests for reprints to: Serdar E. Bulun, M.D., Professor and Chief, Division of Reproductive Biology Research, Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, 303 East Superior Street, 4-123, Chicago, Illinois 60611. E-mail: s-bulun{at}northwestern.edu.

Context: Products of at least five specific steroidogenic genes, including steroidogenic acute regulatory protein (StAR), which facilitates the entry of cytosolic cholesterol into the mitochondrion, side chain cleavage P450 enzyme, 3β-hydroxysteroid-dehydrogenase-2, 17-hydroxylase/17-20-lyase, and aromatase, which catalyzes the final step, are necessary for the conversion of cholesterol to estrogen. Expression and biological activity of StAR and aromatase were previously demonstrated in endometriosis but not in normal endometrium. Prostaglandin E2 (PGE2) induces aromatase expression via the transcriptional factor steroidogenic factor-1 (SF1) in endometriosis, which is opposed by chicken-ovalbumin upstream-transcription factor (COUP-TF) and Wilms’ tumor-1 (WT1) in endometrium.

Objective: The aim of the study was to demonstrate a complete steroidogenic pathway leading to estrogen biosynthesis in endometriotic cells and the transcriptional mechanisms that regulate basal and PGE2-stimulated estrogen production in endometriotic cells and endometrium.

Results: Compared with normal endometrial tissues, mRNA levels of StAR, side chain cleavage P450, 3β-hydroxysteroid-dehydrogenase-2, 17-hydroxylase/17-20-lyase, aromatase, and SF1 were significantly higher in endometriotic tissues. PGE2 induced the expression of all steroidogenic genes; production of progesterone, estrone, and estradiol; and StAR promoter activity in endometriotic cells. Overexpression of SF1 induced, whereas COUP-TFII or WT1 suppressed, StAR promoter activity. PGE2 induced coordinate binding of SF1 to StAR and aromatase promoters but decreased COUP-TFII binding in endometriotic cells. COUP-TFII or WT1 binding to both promoters was significantly higher in endometrial compared with endometriotic cells.

Conclusion: Endometriotic cells contain the full complement of steroidogenic genes for de novo synthesis of estradiol from cholesterol, which is stimulated by PGE2 via enhanced binding of SF1 to promoters of StAR and aromatase genes in a synchronous fashion.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
A.G. Braundmeier and A.T. Fazleabas
The non-human primate model of endometriosis: research and implications for fecundity
Mol. Hum. Reprod., October 1, 2009; 15(10): 577 - 586.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. K. Banu, J. Lee, V. O. Speights Jr., A. Starzinski-Powitz, and J. A. Arosh
Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NF{kappa}B, and {beta}-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms
Mol. Endocrinol., August 1, 2009; 23(8): 1291 - 1305.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Colette, J. Donnez, and S. E. Bulun
Endometriosis
N. Engl. J. Med., April 30, 2009; 360(18): 1911 - 1912.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society